Complete Genomics (GNOM) Continues Run Following Strong LFR Testing Data
Tweet Send to a FriendGet Alerts GNOM Hot Sheet
Up)
Trade GNOM Now!
Complete Genomics (Nasdaq: GNOM) is up again in early trading, following a 44 percent run Wednesday on positive LFR Testing data.
Volatility is up slightly in early trade as shares are over 8 percent better.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Volatility is up slightly in early trade as shares are over 8 percent better.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Crash in American Electric Power (AEP) & NextEra Energy (NEE) Adds to Jitters
- Fusion-io (FIO) Valuation, Technology Might Attract Buyers
- Investors Brace for Epic Herbalife (HLF) Short Squeeze
Create E-mail Alert Related Categories
Insiders' Blog, Momentum Movers
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
